Marcos supports a new MOU to expand medicine access through flexible pharmacy rules, tackling shortages and boosting healthcare reach.
Key Points Summary
- President Marcos attended the signing of an MOU on medicine access.
- The pilot program allows flexible pharmacy supervision, including telepharmacy.
- The Philippines faces a shortage of 27,500 licensed pharmacists.
- FDA and PRC will oversee compliance with the Pharmacy Act of 2016.
- Pilot areas include Metro Manila, Northern Luzon, Visayas, and Mindanao.
- The program runs until 2027, with possible nationwide rollout.
Marcos Pushes for Fairer Medicine Access
President Ferdinand Marcos Jr. stood alongside regulators and private sector leaders this week as they signed an agreement that could reshape how Filipinos get their prescriptions filled. The Memorandum of Understanding (MOU), which introduces a Regulatory Sandbox Pilot Program for Flexible Supervision of Pharmacies, may not sound headline‑grabbing at first. But for millions of families who struggle with long trips to the nearest drugstore or face empty counters because no pharmacist is available, the promise of better medicine access is no small matter.
The Shortage No One Can Ignore
The numbers are stark. The Philippines is short by an estimated 27,500 licensed pharmacists, according to the Private Sector Advisory Council. That gap has left many community pharmacies unable to comply with the Philippine Pharmacy Act of 2016, which requires at least one licensed pharmacist per outlet.
Anyone who has tried to buy antibiotics in a provincial town knows the frustration: the medicine is there, the pharmacy is open, but no pharmacist is on duty to legally dispense it. Shelves stocked but locked — that’s the reality in many places. The new pilot program is meant to break that bottleneck.
How Flexible Supervision Works
Instead of requiring a pharmacist to be physically present at every branch, the program allows for telepharmacy setups. Through video calls and remote monitoring, a licensed pharmacist in Manila could supervise a pharmacy in Abra or Iloilo. It’s not a perfect substitute for face‑to‑face interaction, but it may be better than leaving patients without any access at all.
The FDA will provide regulatory oversight, while the Professional Regulatory Board of Pharmacy will coordinate with private sector partners to ensure compliance. The pilot will run until 2027, covering areas in Metro Manila, Northern Luzon, the Visayas, and Mindanao.
Why Medicine Access Matters
The World Health Organization has repeatedly stressed that access to essential medicines is a cornerstone of universal healthcare. In the Philippines, where geography alone makes healthcare delivery uneven, medicine access is often the difference between timely treatment and worsening illness.
For families in remote areas, the new program could mean fewer costly trips to city centers. For the government, it’s a step toward its broader goal of universal healthcare.
A Look Abroad: How Others Handle It
Other countries have faced similar dilemmas:
- India has embraced telepharmacy in rural states, allowing one pharmacist to cover multiple outlets.
- The United States has experimented with flexible pharmacist‑to‑pharmacy ratios in rural towns.
- Thailand has integrated community pharmacies into primary healthcare, ensuring even small villages have access to essential drugs.
The Philippines’ pilot appears to borrow from these models, though its success will depend on how well regulators enforce safeguards.
Mixed Reactions
Health experts generally welcome the initiative, though some raise concerns. Public health advocate Dr. Maria Teresa Dizon called it a “practical compromise,” but warned that remote supervision should not replace the pharmacist’s role as a trusted adviser. Patients often rely on pharmacists for guidance on whether to choose a generic or branded drug, or how to manage side effects — conversations that may not translate well over a video call.
Pharmacy owners, meanwhile, see the program as a relief. Many have struggled to keep branches compliant with the law, and flexible supervision could ease that burden without shutting doors.
Transparency and Trust
The MOU emphasizes that patient safety remains the top priority. By involving both the FDA and PRC, the program signals that this isn’t a free‑for‑all deregulation but a carefully monitored experiment. That balance — between flexibility and accountability — may determine whether the public embraces it.
Local Impact
For residents in Abra, Iloilo, and Misamis, the pilot could be transformative. Instead of traveling hours to find a pharmacist, they may soon have legal access to prescriptions in their own towns. It’s a small change on paper, but one that could ripple across communities.
Looking Ahead
The pilot runs until 2027, but its long‑term impact could extend far beyond. If it works, it may pave the way for permanent reforms in pharmacy supervision, ensuring that medicine access becomes a right, not a privilege.
FAQ Section
Q1: What happened in the Marcos MOU on medicine access? President Marcos attended the signing of an MOU introducing flexible pharmacy supervision to improve medicine access nationwide.
Q2: Why is medicine access important in the Philippines? It ensures timely treatment, reduces healthcare costs, and supports universal healthcare goals.
Q3: How does the new program affect people? It allows pharmacists to supervise multiple pharmacies remotely, expanding medicine access to underserved areas.
Q4: What are the latest updates on medicine access in the Philippines? The pilot program will run until 2027 in selected provinces and cities, with possible nationwide expansion.
Q5: Where can I read more about medicine access? Updates are available through the FDA, PRC, and major Philippine news outlets such as inquirer.net
For the Latest News see source below:
Source Link:
For Other Stories:
💡 Want to discover trending apps and offers tailored for you?
👉 Try it now
